We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.


Pharmacovigilance – Products

White pills on a blue background.
Product News

Novartis Kisqali® Reduced the Risk of Cancer Recurrence While Maintaining Quality of Life

Novartis presents new patient-reported outcomes (PRO) data from the Phase III NATALEE trial at the European Society for Medical Oncology (ESMO) Virtual Plenary.
Drug Conjugates

Antibody–Drug Conjugates: A Novel Paradigm for Cancer Therapy

This whitepaper highlights the key molecular components of ADCs and the challenges and opportunities for their future development.
Vaccine Development

Influenza Vaccine Development and Production Solutions

Learn more about influenza vaccine solutions!
Lab-on-a-chip plate technology for screening minute amounts of cancerous tissue.
Product News

Lab-on-Chip Technology for Screening Live Tumor

ScreenIn3D reports on how their proprietary lab-on-a-chip technology is enabling cancer researchers to miniaturize their testing of biopsy tissue samples across a wide range of modalities and to test both single and combination drug therapies.
White tablets pouring out of a pink pill bottle.
Product News

RemeGen's Telitacicept Shows Significant Promise in Phase II Trial for Primary Sjogren's Syndrome

RemeGen Co., Ltd. announced that their Phase II clinical study of telitacicept for the treatment of Primary Sjögren's Syndromein adults has been published.
A female scientist holding a vial.
Product News

Sapient’s High Complexity CLIA Laboratory Receives Accreditation From the College of American Pathologists

Sapient has been awarded accreditation from the College of American Pathologists (CAP).
Cell culture in a 12-well plate.
Product News

InSphero AG and Cosmo Bio Co., Ltd Enter Into Strategic Partnership

InSphero AG and Cosmo Bio Co., Ltd. are announcing a strategic partnership to distribute InSphero’s innovative product portfolio in Japan.
Artistic illustration of antibodies.
Product News

Tillotts Pharma and TVM Capital Life Science Announce Formation of Mage Biologics to Develop Innovative Oral Antibody Therapy for Ulcerative Colitis

TVM Capital Life Science, together with specialty pharma company, Tillotts Pharma has announced that the companies will jointly invest up to USD 28 million in the newly formed U.S.-based biotechnology company, Mage Biologics Inc.
Various types of oral medication on a yellow background.
Product News

Landmark Study Demonstrates Economic Edge of Precision Medicine

A landmark study demonstrates that precision oncology medicines could deliver a superior return on Investment for Pharma R&D vs their one size fits all counterparts.
OncoPro Tumoroid Culture Medium Kit
Product News

Thermo Fisher Scientific Introduces Tumoroid Culture Medium

Thermo Fisher Scientific has announced the launch of the first commercially available culture medium specifically developed for the expansion of patient-derived cancer organoids, from multiple cancer indications.